title: Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.
abstract: Nearly 10% of the estimated 36 million people having HIV worldwide suffer from chronic hepatitis B virus (HBV) infection. The advent of new antiviral agents against HBV and the recent availability of improved molecular diagnostic tools have revolutioned the management of HIV/HBV coinfected patients. The present study represents an update of the current knowledge about HBV/HIV coinfection and an intent to provide practical advise about how to give the best care to HIV-infected persons with chronic hepatitis B.
authors.affiliation: Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain. vsoriano@dragones.es
authors.forename: Vincent
authors.initials: V
authors.lastname: Soriano
authors.forename: Massimo
authors.initials: M
authors.lastname: Puoti
authors.forename: Marion
authors.initials: M
authors.lastname: Peters
authors.forename: Yves
authors.initials: Y
authors.lastname: Benhamou
authors.forename: Mark
authors.initials: M
authors.lastname: Sulkowski
authors.forename: Fabien
authors.initials: F
authors.lastname: Zoulim
authors.forename: Stefan
authors.initials: S
authors.lastname: Mauss
authors.forename: Juergen
authors.initials: J
authors.lastname: Rockstroh
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects; D000998:Antiviral Agents / Q000627:therapeutic use*; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000150:complications*; D017325:Hepatitis B Vaccines / Q000276:immunology; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D016031:Liver Transplantation
chemical_list: D019380:Anti-HIV Agents; D000998:Antiviral Agents; D017325:Hepatitis B Vaccines